FUMAGALLI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 126
NA - Nord America 104
AS - Asia 68
Totale 298
Nazione #
US - Stati Uniti d'America 102
SE - Svezia 43
IT - Italia 42
CN - Cina 35
SG - Singapore 30
RU - Federazione Russa 17
DE - Germania 6
FI - Finlandia 5
IE - Irlanda 3
AT - Austria 2
FR - Francia 2
GB - Regno Unito 2
IN - India 2
MX - Messico 2
PL - Polonia 2
MK - Macedonia 1
NL - Olanda 1
TW - Taiwan 1
Totale 298
Città #
Ashburn 20
Singapore 20
Shanghai 18
Boardman 17
Lawrence 9
Princeton 9
Helsinki 5
Milan 5
Moscow 5
Cernusco sul Naviglio 4
New York 4
Ancona 3
Dallas 3
Dublin 3
Guangzhou 3
Arezzo 2
Beijing 2
Clusone 2
Frankfurt am Main 2
Genoa 2
Guildford 2
Hanover 2
Iztapalapa 2
Los Angeles 2
Pisa 2
Pune 2
Rome 2
Seattle 2
Turin 2
Vienna 2
Vimodrone 2
Washington 2
Amsterdam 1
Bacoli 1
Baltimore 1
Benevento 1
Chiaravalle 1
Foshan 1
Gorle 1
Jiujiang 1
Kassel 1
Macerata 1
Mountain View 1
Novara 1
Segrate 1
Skopje 1
Wuxi 1
Xi'an 1
Totale 178
Nome #
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming 32
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
Isolation of mouse Kupffer cells for phenotypic and functional studies 23
Extracellular HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV pathogenesis 21
A subset of Kupffer cells regulates metabolism through the expression of CD36 21
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability 21
Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion 20
Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming 19
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination 17
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development 16
Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection 16
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence 15
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses 14
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection 13
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus 13
Effector CD8+T cell-derived interleukin-10 enhances acute liver immunopathology 13
A fluorescent reporter model for the visualization and characterization of TDC 11
The interplay of drug therapeutics and immune responses to SARS-CoV-2 11
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses 10
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 9
Therapeutic potential of co-signaling receptor modulation in hepatitis B 7
Totale 345
Categoria #
all - tutte 4.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 1 0 0 0 0 0 0 0
2020/20212 0 0 0 1 0 1 0 0 0 0 0 0
2021/202220 0 0 0 3 1 0 7 2 1 0 2 4
2022/202384 22 19 10 2 2 11 9 7 0 1 0 1
2023/2024152 12 6 10 18 9 17 1 10 11 9 17 32
2024/202583 40 7 12 12 12 0 0 0 0 0 0 0
Totale 345